Bharat Immunological & Biological Corporation Ltd logo

524663

Bharat Immunological & Biological Corporation Ltd

₹30.30

Bharat Immunological & Biological Corporation Ltd Q2 FY2023-2024 Results: Summary

Revenue
₹0.16Cr
Net Profits
₹-4.92Cr
Net Profit Margins
-3075%

Highlights

Revenue:

Bharat Immunological & Biological Corporation Ltd’s revenue fell -99.4% since last year same period to ₹0.16Cr in the Q2 2023-2024. On a quarterly growth basis, Bharat Immunological & Biological Corporation Ltd has generated 60% jump in its revenue since last 3-months.

Net Profits:

Bharat Immunological & Biological Corporation Ltd’s net profit fell -59.74% since last year same period to ₹-4.92Cr in the Q2 2023-2024. On a quarterly growth basis, Bharat Immunological & Biological Corporation Ltd has generated -7.19% fall in its net profits since last 3-months.

Net Profit Margins:

Bharat Immunological & Biological Corporation Ltd’s net profit margin fell -26656.49% since last year same period to -3075% in the Q2 2023-2024. On a quarterly growth basis, Bharat Immunological & Biological Corporation Ltd has generated 33.01% jump in its net profit margins since last 3-months.

FAQs

The revenue for Bharat Immunological & Biological Corporation Ltd in the Q2 results 2023 was ₹0.16Cr.

The net profit for Bharat Immunological & Biological Corporation Ltd in the Q2 results 2023 was ₹-4.92Cr.

The net profit margin for Bharat Immunological & Biological Corporation Ltd in the Q2 results 2023 was -3075%.

The revenue for Bharat Immunological & Biological Corporation Ltd in the Q2 results 2022 was ₹26.80Cr.

The net profit for Bharat Immunological & Biological Corporation Ltd in the Q2 results 2022 was ₹-3.08Cr.

The net profit margin for Bharat Immunological & Biological Corporation Ltd in the Q2 results 2022 was -11.49%.